Albuterol sulfate pressurized inhalation suspension (AS MDI)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Albuterol sulfate pressurized inhalation suspension (AS MDI), covering 2019-07-23 to 2019-07-23. Get the full timeline:
Most recent: Clinical Trial Update: Assessment of the Safety, Efficacy, PK, and Extrapulmonary Pharmacodynamics (PD) of Albuterol Sulfate Pressurized Inhalation Suspension (Hereafter Referred to as AS MDI) Compared to Proventil as an Active Control in Subjects With Asthma [Phase 2]